A Randomized, open label, parallel group, active controlled Pharmacokinetic-Pharmacodynamic Study with Single dose of Lupinâ??s Rituximab and Rocheâ??s Rituximab In patients with Rheumatoid Arthritis - Lupin RTX Study
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Lupin
- 15 Dec 2017 Status changed from active, no longer recruiting to completed.
- 06 Feb 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 01 Sep 2016 New trial record